book cover

5-(1H-indol-3-yl)-1,3-substitutedpyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione as anticancer agents

  • US 11,958,857 B1

  • الصحة - Health

  • 2024

  • مكتب البراءات الأمريكي - US Patent Office

  • Venugopala; Katharigatta N. (Al-Ahsa, SA), Venugopala; Rashmi (Bangalore, IN), Kamat; Vinuta (Bangalore, IN), Kumar; Amit (Bangalore, IN)

  • Methods of treating cancer in a patient by administering 5-(1H-indol-3-yl)-1,3-substituted pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione to a patient in need thereof.